ST. PAUL, Minn., Mar 16, 2009 (BUSINESS WIRE) -- Ecolab Inc. announced today it has partnered with Veltek Associates,
Inc., a provider of solutions used to address the control of particulate
and microbial contamination in pharmaceutical and biotechnology
operations. Through this strategic partnership, Ecolab's Healthcare
business will market Veltek's infection control portfolio to hospital
pharmaceutical labs.
"This collaboration further strengthens Ecolab's healthcare business and
infection prevention portfolio by offering hospitals new products and
processes that meet USP 797 standards to reduce the risk of transmission
of microbes within pharmacy environments," said Susan Nestegard,
Executive Vice President, Global Healthcare. "We are excited to be
working with Veltek, a market leader in contamination control, to
support our customers' infection control efforts across all areas within
their facilities."
USP 797 is a regulation endorsed by the Joint Commission that governs a
range of pharmacy policies and procedures. It is designed both to cut
down on infections transmitted to patients through pharmaceutical
products and to better protect staff working in pharmacies in the course
of their exposure to pharmaceuticals.
With sales of $6 billion and more than 26,000 associates, Ecolab Inc.
(NYSE: ECL) is the global leader in cleaning, sanitizing, food safety
and infection prevention products and services. Ecolab delivers
comprehensive programs and services to the foodservice, food and
beverage processing, healthcare, and hospitality markets in more than
160 countries. More news and information is available at www.ecolab.com.
(ECL-C)
SOURCE: Ecolab Inc.
Ecolab Inc.
Paul Chaffin, 651-293-4009
Copyright Business Wire 2009